More stocks to consider
Alternative stocks to Aspen Pharmacare (JSE:APN)


These are the alternatives to Aspen Pharmacare that fall within the same industry, Pharmaceuticals, or region, South Africa.

How to read the ranks

For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. The higher the rank, the better the stock performs than its peers. And, we do this for six investment strategies:

Value - shows how good of a value the stock is. Green is "inexpensive"; red is "expensive".

Growth - shows a company's growth potential. Green is "high growth" expected; red is "tough times ahead".

Safety - relates to the amount of debt a company has. Green is low debt level; red is high debt level.

Combined Financial - this isn't an average of the first three ranks but rather a consolidated view across several financial indicators. Green = good; red = tread carefully.

(NEW) Sentiment - quantifies professional analyst ratings and holdings as well as market pulse. Green = positive sentiment; red = skepticism (Only available to Premium Subscribers).

(NEW) 360° View - the ultimate rating with all financial and non-financial indicators.

See Aspen Pharmacare Performance

Aspen Pharmacare stock research in summary

aspenpharma.com


Aspen Pharmacare shares are less expensive than other comparable stocks. While they are good value, they are riskily financed, and show below average growth. We recommend evaluating whether the future of the company Aspen Pharmacare is really as difficult as the low price of the stock suggests. If you believe that the future of the company is market-typical or even better, then this could be an argument for a share purchase.


Latest Obermatt Ranks


Log in or sign up to see the new 360° View and Sentiment ranks.

Country South Africa
Industry Pharmaceuticals
Index
Size class Medium

Large companies - similar industry as Aspen Pharmacare

Similar Stocks VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Sun Pharmaceuticals (XL, IN)  Pharmaceuticals
1. Sun Pharmaceuticals (XL, IN)   Pharmaceuticals 35 51 63 49
2. IHH Healthcare (XL, MY)  Health Care Facilities
2. IHH Healthcare (XL, MY)   Health Care Facilities 49 73 13 41

July 24, 2025

Why popular stocks have low ratings

It’s easier said than done. When your stock drops, it’s easy to want to sell it and find a better performer. Think twice, or even three times, before trading. Those fees (especially the hidden ones) can eat up your gains.

Large companies - similar region as Aspen Pharmacare

Similar Stocks VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Vodacom (XL, ZA)  Wireless Telecommunication
1. Vodacom (XL, ZA)   Wireless Telecommunication 67 93 69 91
2. Ambev (XL, BR)  Brewers
2. Ambev (XL, BR)   Brewers 59 81 70 88
3. Suzano (XL, BR)  Paper Products
3. Suzano (XL, BR)   Paper Products 83 75 37 82
4. Astra International (XL, ID)  Automobile Manufacturers
4. Astra International (XL, ID)   Automobile Manufacturers 85 17 85 80
5. MTN (XL, ZA)  Wireless Telecommunication
5. MTN (XL, ZA)   Wireless Telecommunication 67 100 42 79
6. Tech Mahindra (XL, IN)  IT Consulting & oth. Services
6. Tech Mahindra (XL, IN)   IT Consulting & oth. Services 55 69 56 76
7. Vale (XXL, BR)  Steel
7. Vale (XXL, BR)   Steel 86 43 58 76
8. Brookfield Business Partners (XL, BM)  Industrial Conglomerates
8. Brookfield Business Partners (XL, BM)   Industrial Conglomerates 59 89 30 73
9. AngloGold Ashanti (XL, ZA)  Gold Production
9. AngloGold Ashanti (XL, ZA)   Gold Production 46 89 54 71
10. Infosys (XXL, IN)  IT Consulting & oth. Services
10. Infosys (XXL, IN)   IT Consulting & oth. Services 43 61 67 67

July 24, 2025


Find more stock ideas
Use your own criteria to filter for stocks or sign up for the latest Top 10 Stock tips.
Log in or Sign up

Mid sized companies - similar industry as Aspen Pharmacare

Similar Stocks VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Kalbe Farma (M, ID)  Pharmaceuticals
1. Kalbe Farma (M, ID)   Pharmaceuticals 79 53 96 100
2. Aurobindo Pharma (M, IN)  Pharmaceuticals
2. Aurobindo Pharma (M, IN)   Pharmaceuticals 77 63 81 97
3. Cipla (L, IN)  Pharmaceuticals
3. Cipla (L, IN)   Pharmaceuticals 61 57 98 96
4. Hapvida Participações e Investimentos (M, BR)  Health Care Managed
4. Hapvida Participações e Investimentos (M, BR)   Health Care Managed 91 35 49 81
5. Rede D'Or São Luiz (M, BR)  Health Care Facilities
5. Rede D'Or São Luiz (M, BR)   Health Care Facilities 77 73 38 80
6. Lupin (M, IN)  Pharmaceuticals
6. Lupin (M, IN)   Pharmaceuticals 55 73 56 70
7. Ipca Laboratories (M, IN)  Pharmaceuticals
7. Ipca Laboratories (M, IN)   Pharmaceuticals 49 69 57 66
8. Netcare (M, ZA)  Health Care Facilities
8. Netcare (M, ZA)   Health Care Facilities 87 67 15 64
9. Fleury (M, BR)  Health Care Services
9. Fleury (M, BR)   Health Care Services 96 30 35 57
10. Zydus (M, IN)  Pharmaceuticals
10. Zydus (M, IN)   Pharmaceuticals 67 5 64 38

July 24, 2025


Mid sized companies - similar region as Aspen Pharmacare

Similar Stocks VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Tiger Brands (M, ZA)  Packaged Foods & Meats
1. Tiger Brands (M, ZA)   Packaged Foods & Meats 47 100 90 100
2. Harmony (L, ZA)  Gold Production
2. Harmony (L, ZA)   Gold Production 62 91 75 98
3. Telkom (M, ZA)  Integrated Telecommunication
3. Telkom (M, ZA)   Integrated Telecommunication 97 75 84 98
4. Exxaro (M, ZA)  Coal & Consumable Fuels
4. Exxaro (M, ZA)   Coal & Consumable Fuels 82 62 79 94
5. Pepkor (L, ZA)  Apparel Retail
5. Pepkor (L, ZA)   Apparel Retail 45 93 66 92
6. Motus Holdings (M, ZA)  Automotive Retail
6. Motus Holdings (M, ZA)   Automotive Retail 99 35 90 92
7. Absa (M, ZA)  Diversified Banks
7. Absa (M, ZA)   Diversified Banks 91 75 45 91
8. Impala Platinum (M, ZA)  Precious Metals & Minerals
8. Impala Platinum (M, ZA)   Precious Metals & Minerals 28 97 79 88
9. Discovery (M, ZA)  Life & Health Insurance
9. Discovery (M, ZA)   Life & Health Insurance 37 97 88 88
10. Sanlam (M, ZA)  Life & Health Insurance
10. Sanlam (M, ZA)   Life & Health Insurance 74 23 60 83

July 24, 2025



Obermatt Portfolio Performance
We’re so convinced about our research, that we buy our stock tips.
See the performance of the Obermatt portfolio.